BioForce Nanosciences Holdings Inc

Consumer Defensive US BFNH

0.76USD
-0.09(10.59%)

Last update at 2026-06-02T20:00:00Z

Day Range

0.850.85

LowHigh

52 Week Range

0.181.02

LowHigh

Fundamentals

Previous Close 0.85
Market Cap20.11M
Volume290
P/E Ratio-
Dividend Yield-%
Revenue TTM0.00000M
Revenue Per Share TTM-
Gross Profit TTM 0.00436M
Diluted EPS TTM-0.04

Overview
Financials
Peer Comparison
Reports
Stock Research & News
Profile

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Income before tax	-0.48995M	-0.49044M	-0.47195M	-0.48551M	-0.50196M
Minority interest	-	-	-	-	-
Net income	-1.29195M	-0.49044M	-0.47195M	-0.48551M	-0.50196M
Selling general administrative	0.07M	0.07M	0.47M	0.49M	0.50M
Selling and marketing expenses	-	-	-	-	0.42M
Gross profit	0.00000M	0.00000M	0.00000M	0.00000M	0.00000M
Reconciled depreciation	-	-	-	-	-
Ebit	-	-	-0.94390M	-0.48551M	-0.50196M
Ebitda	-0.48995M	-0.49044M	-0.47195M	-0.48551M	-0.50196M
Depreciation and amortization	-	-	0.47M	-	-
Non operating income net other	-	-	-	-	-
Operating income	-0.48995M	-0.49044M	-0.47195M	-0.48551M	-0.50196M
Other operating expenses	0.49M	0.49M	0.47M	0.49M	0.50M
Interest expense	-	-	-	-	0.00000M
Tax provision	-	-	-	-	-
Interest income	-	-	-	-	-
Net interest income	-	-	-	-	-
Extraordinary items	-	-	-	-	-
Non recurring	-	-	-	-	-
Other items	-	-	-	-	-
Income tax expense	-	-	-0.47195M	-	-
Total revenue	0.00000M	0.00000M	0.00000M	0.00000M	0.00000M
Total operating expenses	0.49M	0.49M	0.47M	0.49M	0.50M
Cost of revenue	0.00000M	0.00000M	0.00000M	0.00000M	0.00000M
Total other income expense net	-0.80200M	-	-0.00000M	-	-
Discontinued operations	-	-	-	-	-
Net income from continuing ops	-1.29195M	-0.49044M	-0.47195M	-0.48551M	-0.50196M
Net income applicable to common shares	-	-	-	-0.48551M	-0.50196M
Preferred stock and other adjustments	-	-	-	-	-

Breakdown	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total assets	0.00079M	0.00086M	0.00064M	0.00073M	0.01M
Intangible assets	-	-	-	-	-
Earning assets	-	-	-	-	-
Other current assets	-	-	-	-	0.00004M
Total liab	0.62M	2.30M	1.82M	1.35M	0.87M
Total stockholder equity	-0.61854M	-2.30159M	-1.81923M	-1.34728M	-0.86186M
Deferred long term liab	-	-	-	-	-
Other current liab	0.62M	2.02M	1.82M	1.35M	0.87M
Common stock	0.03M	0.03M	0.03M	0.03M	0.03M
Capital stock	0.03M	0.03M	0.03M	0.03M	0.03M
Retained earnings	-162.41212M	-161.12017M	-160.62973M	-160.15778M	-159.67226M
Other liab	-	-	-	-	-
Good will	-	-	-	-	-
Other assets	-	-	-	-	-
Cash	0.00079M	0.00086M	0.00064M	0.00073M	0.01M
Cash and equivalents	-	-	-	-	-
Total current liabilities	0.62M	2.30M	1.82M	1.35M	0.87M
Current deferred revenue	-	-	-0.22070M	-	-
Net debt	-0.00079M	-0.00086M	-0.00064M	-0.00073M	-0.01111M
Short term debt	-	0.27M	0.22M	-	-
Short long term debt	-	-	-	-	-
Short long term debt total	-	-	0.22M	-	-
Other stockholder equity	161.76M	158.79M	158.78M	158.78M	158.78M
Property plant equipment	-	-	-	-	-
Total current assets	0.00079M	0.00086M	0.00064M	0.00073M	0.01M
Long term investments	-	-	-	-	-
Net tangible assets	-	-	-	-1.34728M	-0.86186M
Short term investments	-	-	-	-	-
Net receivables	-	-	-	-	-
Long term debt	-	-	-	-	-
Inventory	-	-	-	-	-
Accounts payable	0.01M	0.00884M	0.00265M	0.00040M	0.00631M
Total permanent equity	-	-	-	-	-
Noncontrolling interest in consolidated entity	-	-	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-	-	-
Accumulated other comprehensive income	-	-	-	-	-
Additional paid in capital	-	-	-	-	-
Common stock total equity	-	-	-	-	0.03M
Preferred stock total equity	-	-	-	-	-
Retained earnings total equity	-	-	-	-	-159.67226M
Treasury stock	-	-	-	-	-
Accumulated amortization	-	-	-	-	-
Non currrent assets other	-	-	-	-	-
Deferred long term asset charges	-	-	-	-	-
Non current assets total	0.00000M	0.00000M	0.00000M	0.00000M	0.00000M
Capital lease obligations	-	-	-	-	-
Long term debt total	-	-	-	-	-

Breakdown	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Investments	-	0.00000M	0.00000M	0.00000M	0.00000M
Change to liabilities	-	-	-	-0.00592M	0.00122M
Total cashflows from investing activities	-	-	-	-	-
Net borrowings	-	-	-	0.06M	0.05M
Total cash from financing activities	0.07M	0.06M	0.05M	0.06M	0.05M
Change to operating activities	-	-	-	0.42M	0.42M
Net income	-1.29195M	-0.49044M	-0.47195M	-0.48551M	-0.50196M
Change in cash	-0.00008M	0.00022M	-0.00010M	-0.01037M	-0.02876M
Begin period cash flow	0.00086M	0.00064M	0.00073M	0.01M	0.04M
End period cash flow	0.00079M	0.00086M	0.00064M	0.00073M	0.01M
Total cash from operating activities	-0.06515M	-0.06125M	-0.04670M	-0.06839M	-0.07777M
Issuance of capital stock	0.00000M	0.00808M	0.00000M	0.00010M	-
Depreciation	-	-	-	-	-
Other cashflows from investing activities	-	-	-	-	-
Dividends paid	-	-	-	-	-
Change to inventory	-	-	-	-	-
Change to account receivables	-	-	-	-	-
Sale purchase of stock	-	-	-	-	-
Other cashflows from financing activities	0.07M	0.05M	0.05M	0.06M	0.05M
Change to netincome	-	-	-	-	-
Capital expenditures	0.00000M	0.00000M	0.00000M	0.00000M	0.00000M
Change receivables	-	-	-	-	-
Cash flows other operating	-	-	-	-	-0.00004M
Exchange rate changes	-	-	-	-	-
Cash and cash equivalents changes	-	-	-	-	-0.02876M
Change in working capital	0.42M	0.43M	0.43M	0.42M	0.42M
Stock based compensation	0.42M	0.42M	-	0.42M	0.42M
Other non cash items	0.81M	0.43M	-0.00225M	-0.42300M	-0.42300M
Free cash flow	-0.06515M	-0.06125M	-0.04670M	-0.06839M	-0.07777M

Peer Comparison

Sector: Consumer Defensive Industry: Packaged Foods

Company	Change (USD)	Price (USD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to Revenue (x)	Enterprise Value to EBITDA (x)
BFNH BioForce Nanosciences Holdings Inc	-0.09 10.59%	0.76	-	-	3840.95	866.24	3843.22	-102.8852
NSRGF Nestle SA	- -%	97.05	26.86	18.76	3.13	7.10	3.81	21.70
NSRGY Nestle SA ADR	-0.83 0.84%	97.72	26.82	18.66	3.18	7.07	3.81	21.70
GPDNF Danone S.A	2.25 3.18%	73.10	25.33	17.39	1.97	2.55	1.88	11.70
DANOY Danone PK	-0.02 0.13%	14.89	24.23	17.64	1.88	2.57	1.88	11.70

Reports Covered

View All

Profile

BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It also sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online at www.bioforceeclipse.com, as well as through social media and telemarketing channels. BioForce Nanosciences Holdings, Inc. is based in Virginia Beach, Virginia.

BioForce Nanosciences Holdings Inc

2020 General Booth Boulevard, Virginia Beach, VA, United States, 23454

757 306 6090
https://www.bioforceeclipse.com
Employees : 3

Key Executives

Name	Title	Year Born
Mr. Steven Gagnon	Co-Chief Exec. Officer	1962
Mr. John LaViolette	Co-Chief Exec. Officer	1961
Mr. Aleksandr Shapiro	Pres	1960
Mr. Richard Kaiser	CFO, Corp. Sec., Corp. Governance Officer, Principal Accounting Officer & Director	1966
Mr. Richard Kaiser	CFO, Corporate Secretary, Corporate Governance Officer, Principal Accounting Officer & Director	1966
Mr. Steven Gagnon	Co-Chief Executive Officer	1962
Mr. John LaViolette	Co-Chief Executive Officer	1962
Mr. Aleksandr Shapiro	President	1963

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.